Biopharmaceuticals (includes Biologics and Drugs)
Jewell Martin, MA, MBA, PMP, RAC
Director for US Regulatory Policy
BioMarin Pharmaceutical, Inc.
Kathleen Sheridan, MS
Manager
PricewaterhouseCoopers (PwC)
Selena Daniels, PharmD, PhD
Deputy Director, Division of Clinical Outcome Assessment
FDA / CDER